Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Dexamethasone vs Tacrolimus for Oral cGVHD
NCT00686855Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Aug 2008
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tacrolimus + Wuzhi capsule in chronic graft-versus-host disease (cGVHD) (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Response Rate (Sensitivity Score) at 4 weeks. Started Aug 2008; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT00686855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00686855.